Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer. Jiang K, Lai CH, Dong S, Lee CP, et al. Gut 2026 Jul 15:gutjnl-2025-337545. doi: 10.1136/gutjnl-2025-337545.

Read + Share

Amedeo Smart

Independent Medical Education

Jiang K, Lai CH, Dong S, Lee CP, et al. Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer. Gut 2026 Jul 15:gutjnl-2025-337545. doi: 10.1136/gutjnl-2025-337545.
PMID: 42457620